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In most scientific fields, and in biomedical research in particular, there have long been many
discussions on how to improve research practices and methods. The trend has increased in re-
cent years, as illustrated by the series on “reducing waste,” published in The Lancet in January
2014 [1], or by the recent essay by John Ioannidis on how to make published results more true
[2], which echoes his earlier provocative paper entitled “Why most published research findings
are false” [3]. One of the important aspects underlying these discussions is that biomedical liter-
ature is most often overoptimistic with respect to, for example, the superiority of a new therapy
or the strength of association between a risk factor and an outcome. Published results appear
more significant, more spectacular, or sometimes more intuitive—in a word, more “satisfacto-
ry”—to authors and readers than they actually would if they reflected the truth. Causes of this
problem are diverse, numerous, and interrelated. The effects of “fishing for significance” strate-
gies or selective/incomplete reporting are exacerbated by design issues (e.g., small sample sizes,
many investigated features) [3] or publication bias [4], to cite only a few of the factors at work.
Research and guidelines on how to reduce overoptimistic reporting in the context of
computational research, including computational biology as an important special case, howev-
er, are surprisingly scarce. Many methodological articles published in computational literature
report the (vastly) superior performance of new methods [5], too often in general terms and—
directly or indirectly—implying that the presented positive results are generalizable to other
settings. Such overoptimistic reporting confuses readers, makes literature less credible and
more difficult to interpret, and might even ultimately lead to a waste of resources in some
cases. Here I take advantage of the popular “ten-simple-rules” format [6] to address the prob-
lem of overoptimistic reporting in methodological computational biology research, that is pa-
pers—termed “methodological papers” here—devoted primarily to the development and
testing of new computational methods (intended to be used by other researchers on other data
in the future) rather than to the biological question itself or the specific dataset at hand.
Rule 1: Assess the NewMethod
If your goal is to present a new method and convince readers to use it, assess this new method.
Applying it to data to answer a biological question and obtaining plausible, interesting results
is nice. But this is not sufficient to establish that the new method has advantages over existing
methods, nor is it adequate in providing trustworthy biological results—since the validity of
the computational method has not yet been assessed. It is not impossible—but it is difficult—to
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both assess a new computational method and address a relevant biological question in the
same article. The assessment of the new method may be performed in different ways depending
on the context, for example, by conducting simulations, applying the method to several real
datasets, checking the underlying assumptions in practical examples, etc. Notably, if there exist
competing methods for performing the same task, they should be compared to the new meth-
od; see Rule 2 for more details.
Rule 2: Compare the NewMethod to the Best
A new method will be useful in practice only if it performs better (see Rule 6 for a discussion of
“better performance”) when compared to the best existing methods performing the same task.
The new method should not be compared to old methods no longer in use, to obsolete versions
of currently used methods, or to good methods with suboptimal parameter settings: comparing
the new method to suboptimal competitors will inevitably make it look better than it actually
is. This rule is especially important for research topics common in the literature. For example,
for supervised classification based on high-dimensional omics data, tens or even hundreds of
methods have already been proposed: a new method should not be solely compared to basic
methods such as naive Bayes. See [7] for a more in-depth discussion of this problem. Note,
however, that recent methods are not always publicly available as user-friendly computer pro-
grams, which may make comparison challenging in practice.
Rule 3: Consider Enough Datasets
To establish that a new method works well in practice, it is important to evaluate its perfor-
mance using several datasets, just as it is important to evaluate the efficiency of a new drug
based on several patients before recommending it for use on other patients [5,8]. With this
analogy in mind, it becomes clear that many datasets are needed if one wants to firmly estab-
lish the superiority of a new method, and that the question of “how many” is essentially a sta-
tistical question [9].
For example, if one compares the performances of two methods—as measured by a normal-
ly distributed criterion—on ten datasets, a paired t-test may be used for statistical inference. Be-
yond the t-test itself, one may also, for example, derive a confidence interval for the difference
between the performances of the two methods, apply a multiple testing procedure if more than
two methods are compared, or compute the power of the paired t-test to detect a given differ-
ence considered relevant by the researcher [9].
In simulations, it will generally not be a problem to consider a (very) large number of data-
sets, except in cases where the analysis of each dataset is extremely computationally expensive.
If one could generate and analyse infinitely many datasets for a given simulation setting, there
would be no need to perform a test to assess the difference between the performances of the
considered methods: the distribution of this difference would be known. In practice, one
should generate and analyse as many datasets as computationally feasible.
For comparisons based on real datasets, however, it may be difficult to find—and have ac-
cess to—enough adequate example datasets. For topics such as supervised classification based
on high-dimensional omics data, numerous well-documented datasets can be found in publicly
available databases like ArrayExpress, GEO, and TCGA—to cite only a few. For more complex
or recent research questions or data types, however, it may be difficult to apply the new method
to more than one or two illustrative datasets.
If the data examples are merely meant as illustrations, which is also fine, it should be stated
clearly that they are not intended to be representative of what would happen with similar
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datasets [8]: in this situation, interpretations of and conclusions on the performance of the new
method should be formulated cautiously.
Rule 4: Do Not “Fish” for Datasets
Example datasets should not be selected just because they yield favorable results for the new
method. Similarly, one should not exclude a dataset from the analysis just because it yields bad
results. The dramatic consequences in terms of overoptimism of such a “fishing for datasets”
strategy have been assessed elsewhere through theoretical modeling and simulations [10] and
empirical studies [7]. Ideally, one should define “inclusion criteria” for datasets (e.g., datasets
with a particular size or format, on pre-specified diseases, etc.), apply the methods, and report
all results.
These inclusion criteria should reflect the intended field of application: if most real datasets
have certain features, then the datasets to be selected should also have this feature. For example,
it would be unsuitable to include only large datasets in the study if most datasets in the target
research field are smaller; such a study may even produce misleading results, since the relative
performances of the considered methods may, to some extent, depend on the dataset’s size.
Rule 5: Think of the No-Free-Lunch Theorem and Report
Limitations
No reasonable researcher requires your method to always work better than existing methods.
Think of the widely acknowledged “no-free-lunch theorem” [11]. Methods are not character-
ized by a single criterion; see also Rule 6. Datasets are extremely diverse, and so are the perfor-
mances of methods when applied to them. Referees are supposed to be reasonable researchers,
so they will most likely not prevent the publication of your paper simply because your new
method is not perfect in all situations and in all respects. Do not forget that, and interpret your
results accordingly.
In particular, report limitations of your method and study. In medical literature—those re-
ports on new medical discoveries obtained with an existing data analysis method described
elsewhere—the section on “limitations of the study” is considered crucial. Limitations of the
method’s applicability, practical problems, implementation issues, and pitfalls related to the
study design should also be stated clearly in a methodological paper. This rule is related to Phil-
ip Bourne’s Rule 2 on objectivity in the first ten-rules article [12].
Rule 6: Consider Several Criteria
Do not become obsessed by a single objective performance criterion, such as, in the case of su-
pervised learning, predictor error. Many other aspects of a new method are important, for ex-
ample, its computational efficiency, its generalizability, its conceptual simplicity, its lack of
sensitivity to the choice of parameters or starting values, and its robustness against the violation
of assumptions, to cite only a few. Note that, in computational biology, the ground truth is
often unknown in real data applications, which makes the measurement of performance diffi-
cult. In these situations, the ability of the new method to uncover the truth can be evaluated
using simulations (see Rule 8), and alternative criteria, such as those listed above, can be used
to assess the method’s behaviour in real data settings. Considering several criteria naturally re-
duces overoptimistic reporting because—most often—no method is better with respect to all
criteria. Further, such considerations also provide a more complete picture of the method’s per-
formance and utility.
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Rule 7: Validate Using Independent Data
The new method should be evaluated using data that were not used during the development
phase. For example, consider the case of a new machine learning method for supervised classi-
fication, such as a new variant of support vector machines (SVM). Its prediction error on a real
dataset of moderate size is typically measured through cross-validation (CV) techniques. One
obtains as many cross-validation estimates of predictor error as considered datasets. Now
imagine modifying some of the new method’s characteristics in a trial-and-error process, grad-
ually improving these CV estimates [13]. Ultimately, the CV error estimates could be relatively
small as a result of this optimization process and the new method would seemingly work well if
evaluated using these datasets: the new method would overfit the datasets used for its develop-
ment. But this says nothing about the ability of the new method to work well on other, inde-
pendent datasets—for which the prediction error may be much higher. See also [7] for an
empirical study on the potential impact of such optimization mechanisms in practice. For
proper evaluation, one has to use other—independent—datasets, which are not examined by
the researchers until the new method is fully specified.
Note that this problem is similar to the well-known problem that in machine learning one
should not evaluate a prediction rule on the training data on which it was fit. However, here we
are concerned with the validation of the methods’ general performance rather than with the
validation of results obtained with these methods on a specific dataset. In our example, we con-
sider the evaluation of the general performance of the SVM variant rather than the evaluation
of the prediction rule resulting when this SVM variant is applied to a specific training dataset.
Rule 8: Design Simulations Appropriately
A simulation should ideally encompass different settings (e.g., different data sizes, different
correlation structures, etc.), which roughly reflect the type of data encountered in the intended
area of application. Simulations should not be limited to artificial datasets corresponding exact-
ly to the assumptions underlying the new method, as this would obviously favor the new meth-
od. Other data types should be considered as well. Ultimately, the practical relevance of a
simulation depends on the similarity between the considered simulation settings and the real
datasets in the area of application. Finally, while interpreting simulation results, one should not
forget that simulated datasets represent but a tiny dot in the infinite space of possible parame-
ters and settings, which can be seen as an intrinsic limitation of simulations—needing to be dis-
cussed, as stipulated by Rule 5. In practice, this problem can be stressed, for example, through
phrases such as “in our simulation setting, we found that. . .”
Rule 9: Provide All Information
The new method’s definition, its underlying assumptions, its parameters, the study design,
data preparation steps and, last, but not least, implementation issues and computer codes for
reproducibility purposes [14] should be carefully reported. Whenever possible, data should be
made publicly available so that interested readers can rerun analyses, check results, try alterna-
tive analysis strategies, or better compare the study’s results to that of their own study’s. Re-
porting has been a widely discussed topic in the last few years in biomedical research [15]. We
claim that it also deserves attention in the context of methodological computational research.
High-quality reporting, including, but not limited to, computational reproducibility through
publication of codes and (whenever possible) data, reduces overoptimism and its impact by in-
creasing transparency and allowing readers to better interpret results to counter the potentially
overoptimistic statements of the authors.
PLOS Computational Biology | DOI:10.1371/journal.pcbi.1004191 April 23, 2015 4 / 6
Rule 10: Read the Other Ten Simple Rules Articles
Some rules presented in other ten-simple-rules articles are also directly or indirectly related to
overoptimistic reporting, for instance, those on writing papers [16], better figures [17], getting
published [12], efficient computational research [18], and reproducible research [14].
Conclusion
Some amount of overoptimism is certainly unavoidable in literature. From a purely statistical
point of view, type I error is non-zero even if a test is performed correctly. Correspondingly,
one cannot expect literature to be free of false positive research findings.
Of crucial note is that the problem of overoptimism is related to publication policies and
publication bias. As long as journal editors and referees reject sound studies on sensible ideas
simply because the new method was not vastly superior to existing methods, authors will al-
ways have to be somewhat overoptimistic (possibly also including ourselves!). Reducing the so-
called publication bias in the context of methodological research is a challenge that still has to
be addressed both from an epistemological point of view (what is actually publication bias?)
and from a practical/editorial perspective (which reduction measures could be reasonably un-
dertaken by journals?).
To conclude, overoptimistic reporting is a problem with multiple facets. Advice to authors
and solutions to reduce overoptimism should go beyond a ten-rules article. However, following
the ten simple rules above can have a considerable influence on alleviating the problem of over-
optimism in reporting.
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